August 3, 2011

Concerns over FDA loosening conflict of interest rules

Posted By

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Barbara Duck

August 3, 2011 at 12:28 pm

This is tough topic and recently I actually gave the FDA a break on the device side with not being able to find enough engineers and companies all across the US have that problem as well. Intel had said they can’t find enough and need to find engineers over seas.
I don’t know if we truly have enough “experts” any more to use the name but we certain have a lot of smart people:) I think technology bites at the word expert quite often with the rapid pace we live in today.
The post I made a few weeks ago included a video from Robert Scoble and it’s probably one of his best as he gets personal about the talent search in this country. The pharma side may roll over into this a bit more too as so many are created with computers for a long way of the research before a wet lab is ever created too.
http://ducknetweb.blogspot.com/2011/07/fda-and-medical-devices-who-doesnt-get.html
Anyway on the device side of the FDA experts I gave them a bit of a break here and it’s a tough subject.

COMMENTS button We welcome comments, which users can leave at the end of any of our systematic story reviews or at the end of any of our blog posts.

But before leaving a comment, please review these notes about our policy.

You are responsible for any comments you leave on this site.

This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.

We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.

We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.

There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”

The authors of the Retraction Watch comments policy urge commenters:

“Shed light, not just heat. Facts, challenges, disagreements, corrections — those are all fine. Attacking the person, instead of the idea or the interpretation, is neither acceptable nor helpful.”

We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.

And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.

The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.